PASS-01: Stratifying Pancreatic Adenocarcinoma Signature for Treatment

Jennifer Knox, MD, of Princess Margaret Cancer Center, details the early results of the PASS-01 trial, which looked at pancreatic adenocarcinoma signature stratification for treatment.

She shares the main challenges in treating metastatic disease, how the design of PASS-01 addresses these challenges through molecular and genomic profiling, and what early outcomes results suggest about the utility of signature stratification for treatment.